Full Press Release Details
• The Ensign Group, Inc. (NASDAQ: ENSG) shareholders should email fletcher@fmoorelaw.com
NEW YORK, Oct. 20, 2026 /PRNewswire/ --
What Happened?
Ensign is a healthcare services company that operates skilled nursing, senior living, and rehabilitative care facilities through affiliated providers. The company relies heavily on Medicare and Medicaid reimbursements, making patient care, staffing, billing, and regulatory compliance central to its business model.
It is alleged Ensign represented that quality patient care was central to its business, described its clinical outcomes and CMS ratings, and characterized regulatory and compliance risks as contingencies.
On June 8, 2026, Hunterbrook Media published "Ensign: The Nursing Home Empire Built on Fatal Neglect," based on a five-month investigation. The report alleged that Ensign acquired distressed nursing facilities, reduced registered-nurse and other skilled-care hours, used self-reported data to improve quality ratings, and generated profits by providing less care than residents required despite receiving public funds based on patient acuity.
On this news, the price of Ensign stock fell $13.88 per share, or 8.15%, from a closing price of $170.30 per share on June 5, 2026, to $156.42 per share on June 8, 2026.
If you own The Ensign Group, Inc. (NASDAQ: ENSG) securities, please contact Fletcher Moore at fletcher@fmoorelaw.com.
You may be able to seek monetary damages, corporate governance reforms, reimbursement to the company, and a court approved incentive award at no cost to you whatsoever. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
MOORE LAW PLLC 30 Wall Street, 8th Floor New York, NY 10005 fletcher@fmoorelaw.com
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.